Pernix Therapeutics (PTX) Reports Q2 Loss of $0.47/Share

August 11, 2016 4:23 PM EDT
Get Alerts PTX Hot Sheet
Trade PTX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Pernix Therapeutics (NASDAQ: PTX) reported Q2 EPS of ($0.47), versus ($0.62) reported last year. Revenue for the quarter came in at $36.75 million, versus $46.98 million reported last year.

For earnings history and earnings-related data on Pernix Therapeutics (PTX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment